NEPTUNE DIGITAL ASSETS CORP
NPPTF
Intchains Group
ICG
Bitdeer Technologies
BTDR
BIGG DIGITAL ASSETS INC
BBKCF
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
ARWR Arrowhead Pharmaceuticals
- 26.070
- -0.270-1.03%
Close Dec 3 16:00 ET
- 26.250
- +0.180+0.69%
Post 20:01 ET
3.24BMarket Cap-5214P/E (TTM)
26.990High26.005Low1.66MVolume26.270Open26.340Pre Close43.74MTurnover1.50%Turnover RatioLossP/E (Static)124.43MShares39.83052wk High17.50P/B2.88BFloat Cap17.05052wk Low--Dividend TTM110.65MShs Float162.500Historical High--Div YieldTTM3.74%Amplitude1.200Historical Low26.411Avg Price1Lot Size
About Arrowhead Pharmaceuticals Company
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Company Profile
SymbolARWR
Company NameArrowhead Pharmaceuticals
Listing DateJun 16, 1993
Issue Price3.60
Founded1989
CEODr. Christopher Anzalone,PhD
MarketNASDAQ
Employees609
Fiscal Year Ends09-30
Address177 East Colorado Boulevard,Suite 700
CityPasadena
ProvinceCalifornia
CountryUnited States of America
Zip Code91105
Phone1-626-304-3400
Company Executives
- Name
- Position
- Salary
- Dr. Christopher Anzalone,PhD
- Director, Chief Executive Officer and President
- 9.92M
- Kenneth Myszkowski
- Chief Financial Officer and Principal Accounting Officer
- 3.12M
- Patrick C. O'Brien
- Chief Operating Officer, General Counsel, Chief Compliance Officer and Corporate Secretary
- 3.31M
- Tracie Oliver
- Chief Commercial Officer
- --
- Dr. Douglass Given, PhD
- Chairman of the Board
- 474.60K
- Victoria Vakiener
- Independent Director
- 452.10K
- William D. Waddill
- Independent Director
- 469.60K
- Dr. Michael S. Perry, PhD
- Independent Director
- 459.60K
- Dr. Mauro Ferrari
- Independent Director
- 459.60K
- Dr. Hongbo Lu, PhD
- Independent Director
- --
- Dr. Adeoye Olukotun, M.D.,M.P.H.
- Independent Director
- 459.60K
- James Hamilton
- Chief of Discovery and Translational Medicine
- 3.05M
- Dr. Bruce D. Given, M.D.
- Chief Medical Scientist
- --
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.